AU Patent

AU9265698A — Mpl-receptor ligands, process for their preparation, medicaments containing themand their use for the treatment and prevention of thrombocytopaenia and anaemia

Assigned to Roche Diagnostics GmbH · Expires 1999-03-22 · 27y expired

What this patent protects

Patent listed against avatrombopag-maleate.

Drugs covered by this patent

avatrombopag-maleate (AVATROMBOPAG MALEATE)

Patent Metadata

Patent number: AU9265698A
Jurisdiction: AU
Classification: —
Expires: 1999-03-22
Drug substance claim: No
Drug product claim: No
Assignee: Roche Diagnostics GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.